Anticalcifying nanoparticle antibody titer is an independent risk factor for coronary artery calcification

Coronary Artery Disease

Volumn 22, Issue 6, 2011, Pages 394-400

  Tulunay Kaya, Cansin ^a   Sinan Ertas, Fatih ^a   Hasan, Taner ^a   Candemir, Basar ^a   Ozdol, Cagdas ^a   Arikan Akan, Ozay ^a   Kocum, Tolga ^b   Dincer, Irem ^a   Sahin, Mustafa ^c   Atmaca, Yusuf ^a   Conkbayr, Cenk ^a   Erol, Cetin ^a  

^a ANKARA UNIVERSITY   (Turkey)

^b Di kapi Yildirim Beyazit Research Hospital   (Turkey)

^c BASKENT UNIVERSITY   (Turkey)

Author keywords

antibody; calcifying nanoparticles; coronary artery calcification; electron beam computed tomography; multidetector computed tomography; nanobacteria

Indexed keywords

ANTICALCIFYING NANOPARTICLE ANTIBODY; BACTERIUM ANTIBODY; CALCIUM; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; IMMUNOGLOBULIN G ANTIBODY; UNCLASSIFIED DRUG;

ADULT; AGE; AGED; ANTIBODY TITER; ARTICLE; BLOOD SAMPLING; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY ARTERY CALCIFICATION; DIABETES MELLITUS; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN TISSUE; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MULTIDETECTOR COMPUTED TOMOGRAPHY; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES; CALCIFYING NANOPARTICLES; CALCINOSIS; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TOMOGRAPHY, X-RAY COMPUTED; TURKEY;

EID: 80051786111     PISSN: 09546928     EISSN: 14735830     Source Type: Journal    
DOI: 10.1097/MCA.0b013e3283487d7f     Document Type: Article

References (66)

1. Greenland P, LaBree L, Azen SP, Doherty TM, Detrano RC. Coronary artery calcium score combined with Framingham score for risk prediction in asymptomatic individuals. JAMA 2004;291:210-215. (Pubitemid 38082815)
2. Detrano RC, Doherty TM, Davies MJ, Stary HC. Predicting coronary events with coronary calcium: pathophysiologic and clinical problems. Curr Probl Cardiol 2000;25:374-402.
3. Hayden MR, Tyagi SC, Kolb L, Sowers JR, Khanna R. Vascular ossification - calcification in metabolic syndrome, type 2 diabetes mellitus, chronic kidney disease, and calciphylaxis - calcific uremic arteriolopathy: the emerging role of sodium thiosulfate. Cardiovasc Diabetol 2005;4:4.
4. Miller VM, Rodgers G, Charlesworth JA, Kirkland B, Severson SR, Rasmussen TE, et al. Evidence of nanobacterial-like structures in calcified human arteries and cardiac valves. Am J Physiol Heart Circ Physiol 2004;287:H1115-H11124.
5. Puskas LG, Tiszlavicz L, Razga Z, Torday LL, Krenacs T, Papp JG, et al. Detection of nanobacteria-like particles in human atherosclerotic plaques. Acta Biol Hung 2005;56:233-245. (Pubitemid 41238271)
6. Kajander EO, Ciftcioglu N. Nanobacteria: an alternative mechanism for pathogenic intra-and extracellular calcification and stone formation. Proc Natl Acad Sci 1998;95:8274-8279. (Pubitemid 28326103)
7. Barr SC, Linke RA, Janssen D, Guard CL, Smith MC, Daugherty CS, et al. Detection of biofilm formation and nanobacteria under long-term cell culture conditions in serum samples of cattle, goats, cats, and dogs. Am J Vet Res 2003;64:176-182. (Pubitemid 36181659)
8. Kajander EO, Kuronen I, Akerman KK, Pelttari A, Ciftcioglu N. Nanobacteria from blood: the smallest culturable autonomously replicating agent on Earth. Proc SPIE 1997;3111:420-428.
9. Breitschwerdt EB, Sontakke S, Cannedy A, Hancock SI, Bradley JM. Infection with Bartonella weissii and detection of Nanobacterium antigens in a North Carolina beef herd. J Clin Microbiol 2001;39:879-882. (Pubitemid 32209694)
10. Ciftcioglu N, Kuronen I, Akerman K, Hiltunen E, Laukkanen J, Kajander EO. A new potential threat in antigen and antibody product: nanobacteria. In: Brown F, Burton D, Doherty P, Mekalanos J, Norrby E, editors. Vaccines. Cold Spring Harbor: Cold Spring Harbor Laboratory Press; 1997. pp. 99-103.
11. Åkerman K, Kuronen I, Kajander EO. Scanning electron microscopy of nanobacteria: novel biofilm producing organisms in blood. Scanning 1993;15:90-91.
12. Ciftcioglu N, Kajander EO. Interaction of nanobacteria with cultured mammalian cells. Pathophysiology 1998;4:59-70.
13. Vali H, McKee MD, Ciftcioglu N, Sears SK, Plows FL, Chevet E, et al. Nanoforms: a new type of protein-associated mineralization. Geochim Cosmochim Acta 2001;65:63-74. (Pubitemid 32185416)
14. Kajander EO. Nanobacteria: propagating calcifying nanoparticles. Lett Appl Microbiol 2006;42:549-552.
15. Cisar JO, Xu DQ, Thompson J, Swaim W, Hu L, Kopecko DJ. An alternative interpretation of nanobacteria-induced biomineralization. Proc Natl Acad Sci U S A 2000;97:11511-11515.
16. Ciftcioglu N, Haddad RS, Golden DC, Morrison DR, McKay DS. A potential cause for kidney stone formation during space flights: enhanced growth of nanobacteria in microgravity. Kidney Int 2005;67:483-491. (Pubitemid 40139840)
17. Ciftcioglu N, Bjórklund M, Kuorikoski K, Bergstrom K, Kajander EO. Nanobacteria: an infectious cause for kidney stone formation. Kidney Int 1999;56:1893-1898. (Pubitemid 29518191)
18. Khullar M, Sharma SK, Singh SK, Bajwa P, Sheikh FA, Relan V, et al. Morphological and immunological characteristics of nanobacteria from human renal stones of a north Indian population. Urol Res 2004;32:190-195. (Pubitemid 38915685)
19. Shiekh FA, Khullar M, Singh SK. Lithogenesis: induction of renal calcifications by nanobacteria. Urol Res 2006;34:53-57. (Pubitemid 43234715)
20. Hjelle JT, Miller-Hjelle MA, Poxton IR, Kajander EO, Ciftcioglu N, Jones ML, et al. Endotoxin and nanobacteria in polycystic kidney disease. Kidney Int 2000;57:2360-2374. (Pubitemid 30340735)
21. Kajander EO, Ciftcioglu N, Miller-Hjelle MA, Hjelle JT. Nanobacteria: controversial pathogens in nephrolithiasis and polycystic kidney disease. Curr Opin Nephrol Hypertens 2001;10:445-452. (Pubitemid 32424037)
22. Wen Y, Li YG, Yang ZL, Wang XC, Wei H, Liu W, et al. Detection of nanobacteria in serum, bile and gallbladder mucosa of patients with cholecystolithiasis. Chin Med J 2005;118:421-424. (Pubitemid 40378581)
23. Sedivy R, Battistutti WB. Nanobacteria promote crystallization of psammoma bodies in ovarian cancer. APMIS 2003;111:951-954. (Pubitemid 37352613)
24. Hudelist G, Singer CF, Kubista E, Manavi M, Mueller R, Pischinger K, et al. Presence of nanobacteria in psammoma bodies of ovarian cancer: evidence for pathogenetic role in intratumoral biomineralization. Histopathology 2004;45:633-637. (Pubitemid 40029824)
25. Altundag K, Altundag O, Akyurek S, Atik MA. Possible association between nanobacteria and malignant microcalcifications in breast cancer. Breast J 2006;12:287.
26. Sommer AP. Peripheral neuropathy and light: preliminary report indicating prevalence of nanobacteria in HIV. J Proteome Res 2003;2:665-666. (Pubitemid 38017113)
27. Sommer AP. Could reduced bone mineral densities in HIV be caused by nanobacteria? J Proteome Res 2004;3:670-672. (Pubitemid 39207377)
28. Ciftcioglu N, McKay DS, Kajander EO. Association between nanobacteria and periodontal disease. Circulation 2003;108:e58-e59.
29. Wood HM, Shoskes DA. The role of nanobacteria in urologic disease. World J Urol 2006;24:51-54. (Pubitemid 43307380)
30. Shoskes DA, Thomas KD, Gomez E. Anti-nanobacterial therapy for men with chronic prostatitis/chronic pelvic pain syndrome and prostatic stones: preliminary experience. J Urol 2005;173:474-477.
31. Jelic TM, Malas AM, Groves SS, Jin B, Melen PF, Osborne G, et al. Nanobacteria-caused mitral valve calciphylaxis in a man with diabetic renal failure. South Med J 2004;97:194-198. (Pubitemid 38222828)
32. Aho K, Kajander EO. Pitfalls in detection of novel nanoorganisms. J Clin Microbiol 2003;41:3460-3461.
33. Nogueira GV, Silveira L, Martin AA, Zangaro RA, Pacheco MT, Chavantes MC, et al. Raman spectroscopy study of atherosclerosis in human carotid artery. J Biomed Opt 2005;10:031117.
34. Becker A, Epple M, Muller KM, Schmitz I. A comparative study of clinically well-characterized human atherosclerotic plaques with histological, chemical, and ultrastructural methods. J Inorg Biochem 2004;98:2032-2038. (Pubitemid 39488135)
35. Tomazic BB. Physiochemical principles of cardiovascular calcification. Z Kardiol 2001;90(Suppl 3):68-80.
36. Hu YR, Zhao Y, Sun YW, Lü WD, Liu ZL, Li JM, et al. Detection of nanobacteria-like material from calcified cardiac valves with rheumatic heart disease. Cardiovasc Pathol 2010;19:289-292.
37. Agatston AS, Janowitz WR, Hildner FJ, Zusmer NR, Viamonte M Jr, Detrano R. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol 1990;15:827-832. (Pubitemid 20101575)
38. Becker CR, Kleffel T, Crispin A, Knez A, Young J, Schoepf UJ, et al. Coronary artery calcium measurement: agreement of multirow detector and electron beam CT. AJR Am J Roentgenol 2001;176:1295-1298. (Pubitemid 32323277)
39. Becker CR, Schoepf UJ, Reiser MF. Methods for quantification of coronary artery calcifications with electron beam and conventional CT and pushing the spiral CT envelope: new cardiac applications. Int J Card Imaging 2001;17:203-211. (Pubitemid 33121047)
40. Rumberger JA, Brundage BH, Rader DJ, Kondos G. Electron beam computed tomographic coronary calcium scanning: a review and guidelines for use in asymptomatic persons. Mayo Clin Proc 1999;74:243-252. (Pubitemid 29135631)
41. Raggi P, Callister TQ, Cooil B, He ZX, Lippolis NJ, Russo DJ, et al. Identification of patients at increased risk of first unheralded acute myocardial infarction by electron-beam computed tomography. Circulation 2000;101:850-855. 29. (Pubitemid 30117879)
42. Libby P. The vascular biology of atherosclerosis. In: Zipes DP, Libby P, Bonow RO, Braunwald E, editors. Braunwald's heart disease: a textbook of cardiovascular medicine. 7th ed. Philadelphia: Elsevier Saunders Co.; 2005. pp. 921-938.
43. Strong JP, Malcom GT, McMahan CA, Tracy RE, Newman WP 3rd, Herderick EE, et al.; Pathobiological Determinants of Atherosclerosis in Youth Research Group. Prevalence and extent of atherosclerosis inadolescents and young adults: implications for prevention from the Pathobiological Determinants of Atherosclerosis in Youth Study. JAMA 1999;281:727-735. (Pubitemid 29113454)
44. Trion A, Van der Laarse A. Vascular smooth muscle cells and calcification in atherosclerosis. Am Heart J 2004;147:808-813.
45. Schmermund A, Móhlenkamp S, Erbel R. Coronary artery calcium and its relationship to coronary artery disease. Cardiol Clin 2003;21:521-534. (Pubitemid 37549524)
46. Doherty TM, Fitzpatrick MA, Shaheen A, Rajavashisth TB, Detrano RC. Genetic determinants of arterial calcification associated with atherosclerosis. Mayo Clin Proc 2004;79:197-210. (Pubitemid 38140804)
47. Doherty TM, Detrano RC, Mautner SL, Mautner GC, Shavelle RM. Coronary calcium: the good, the bad, and the uncertain. Am Heart J 1999;137:806-814. (Pubitemid 29226289)
48. Oh J, Wunsch R, Turzer M, Bahner M, Raggi P, Querfeld U, et al. Advanced coronary and carotid arteriopathy in young adults with childhood-onset chronic renal failure. Circulation 2002;106:100-105. (Pubitemid 34747448)
49. Raggi P, Boulay A, Chasan-Taber S, Amin N, Dillon M, Burke SK, et al. Cardiac calcification in adult hemodialysis patients: a link between endstage renal disease and cardiovascular disease? J Am Coll Cardiol 2002;39:695-701. (Pubitemid 34158168)
50. Raoult D, Drancourt M, Azza S, Nappez C, Guieu R, Rolain JM, et al. Nanobacteria are mineralo fetuin complexes. PLoS Pathog 2008;4:e41.
51. Young JD, Martel J. The rise and fall of nanobacteria. Sci Am 2010;302:52-59.
52. Wu CY, Martel J, Young D, Young JD. Fetuin-a/albumin-mineral complexes resembling serum calcium granules and putative nanobacteria: demonstration of a dual inhibition-seeding concept. PLoS One 2009;4:e8058.
53. Young JD, Martel J, Young D, Young A, Hung CM, Young L, et al. Characterization of granulations of calcium and apatite in serum as pleomorphic mineralo-protein complexes and as precursors of putative nanobacteria. PLoS One 2009;4:e5421.
54. Young JD, Martel J, Young L, Wu CY, Young A, Young D. Putative nanobacteria represent physiological remnants and culture by-products of normal calcium homeostasis. PLoS One 2009;4:e4417.
55. Martel J, Young JD. Purported nanobacteria in human blood as calcium carbonate nanoparticles. Proc Natl Acad Sci U S A 2008;105:5549-5554. (Pubitemid 351753900)
56. Zhu J, Katz RJ, Quyyumi AA, Canos DA, Rott D, Csako G, et al. Association of serum antibodies to heat-shock protein 65 with coronary calcification levels. Circulation 2004;109:236-241.
57. Sherer Y, Shemesh J, Trenebaum A, Praprotnik S, Harats D, Fisman E, et al. Coronary calcium and anti-cardiolipin antibody are elevated in patients with typical chest pain. Am J Cardiol 2000;86:1306-1311.
58. Kondos GT, Hoff JA, Sevrukov A, Daviglus ML, Garside DB, Devries SS, et al. Electron-beam tomography coronary artery calcium and cardiac events: a 37-month follow-up of 5635 initially asymptomatic low to intermediate-risk adults. Circulation 2003;107:2571-2576. (Pubitemid 36628938)
59. Wong ND, Kouwabunpat D, Vo AN, Detrano RC, Eiseserg H, Goel M, et al. Coronary calcium and atherosclerosis by ultrafast computed tomography in asymptomatic men and women: relation to age and risk factors. Am Heart J 1994;127:422-430. (Pubitemid 24063236)
60. Shaw LJ, Raggi P, Berman DS, Callister TQ. Coronary artery calcium as a measure of biologic age. Atherosclerosis 2006;188:112-119. (Pubitemid 44142526)
61. O'Malley PG, Taylor AJ, Jackson JL, Doherty TM, Detrano RC. Prognostic value of coronary electron-beam computed tomography for coronary heart disease events in asymptomatic populations. Am J Cardiol 2000;85:945-948. (Pubitemid 30176130)
62. Shemesh J, Morag-Koren N, Goldbourt U, Grossman E, Tenenbaum A, Fisman EZ, et al. Coronary calcium by spiral computed tomography predicts cardiovascular events in high-risk hypertensive patients. J Hypertens 2004;22:605-610. (Pubitemid 38368495)
63. Raggi P, Shaw LJ, Berman DS, Callister TQ. Prognostic value of coronary artery calcium screening in subjects with and without diabetes. J Am Coll Cardiol 2004;43:1663-1669. (Pubitemid 38561350)
64. Pletcher MJ, Tice JA, Pignone M, Browner WS. Using the coronary artery calcium score to predict coronary heart disease events: a systematic review and metaanalysis. Arch Intern Med 2004;164:1285-1292. (Pubitemid 38828878)
65. Ciftcioglu N, Miller-Hjelle MA, Hjelle JT, Kajander EO. Inhibitionof nanobacteria by antimicrobial drugs as measured by a modified microdilution method. Antimicrob Agents Chemother 2002;46:2077-2086. (Pubitemid 34665900)
66. Maniscalco B, Taylor KA. Calcification in coronary artery disease can be reversed by EDTA-tetracycline long-term chemotherapy. Pathophysiology 2004;11:95-101. (Pubitemid 39201416)